November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Vadim Koshkin: Our recent work highlighting a Grey Zone in metastatic urothelial carcinoma after enfortumab vedotin/pembrolizumab
Jun 1, 2024, 23:26

Vadim Koshkin: Our recent work highlighting a Grey Zone in metastatic urothelial carcinoma after enfortumab vedotin/pembrolizumab

Vadim Koshkin, Assistant Professor at University of California, San Francisco, shared a post on X/Twitter:

Our recent work in European Urology Focus with Jason Brown, Case Comp Cancer Center highlighting a Grey Zone in metastatic urothelial carcinoma after enfortumab vedotin/pembrolizumab.

Therapies After Progression on Enfortumab Vedotin and Pembrolizumab: Navigating Second-line Options for Metastatic Urothelial Carcinoma in the New Treatment Landscape.”

Source: Vadim Koshkin/X